Sulzer is to acquire Swiss-German privately held drug delivery device developer and manufacturer Haselmeier for an enterprise value of €100m (US$118.3m). Haselmeier is an own-IP provider of drug delivery devices…
Sulzer is to acquire Swiss-German privately held drug delivery device developer and manufacturer Haselmeier for an enterprise value of €100m (US$118.3m). Haselmeier is an own-IP provider of drug delivery devices…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


